Skip to main content
. 2015 Mar 24;10(3):e0120320. doi: 10.1371/journal.pone.0120320

Fig 3. Comparison of overall survival and recurrence free survival after mastectomy in ALK CNG (-) patients and ALK CNG (+) patients.

Fig 3

(A) overall survival and (B) recurrence free survival. ALK, anaplastic lymphoma kinase; CNG, copy number gain.